Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

German Ott

Showing results (321-330 of 374) with videos related to

Pageof 38
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2024
Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter ApproachCatalina Amador, Dennis D Weisenburger, Ana Gomez, et al.
Leukemia|February 19, 2026
Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphomaDaniel Filip, Katerina Litzmanova, Androniki Michaelou, et al.
Genes, Chromosomes & Cancer|January 23, 2025
MicroRNA Expression in High-Grade B-Cell Lymphoma With 11q AberrationGioia Di Stefano, Anja Fischer, Emil Chteinberg, et al.
Nature Communications|July 6, 2022
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to ageBirgit Burkhardt, Ulf Michgehl, Jonas Rohde, et al.
The American Journal of Pathology|June 25, 2004
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphomaJaveed Iqbal, Warren G Sanger, Douglas E Horsman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOPXin Huang, Bin Meng, Javeed Iqbal, et al.
Blood|February 15, 2007
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survivalAdrian Wiestner, Mahsa Tehrani, Michael Chiorazzi, et al.
Leukemia|July 19, 2022
PARP14 is a novel target in STAT6 mutant follicular lymphomaMichael Mentz, William Keay, Carolin Dorothea Strobl, et al.
Blood|September 21, 2013
EZH2 mutations are frequent and represent an early event in follicular lymphomaCsaba Bödör, Vera Grossmann, Nikolay Popov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2017
New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded BiopsiesDavid W Scott, Pau Abrisqueta, George W Wright, et al.
Pageof 38

Showing results (321-330 of 374) with videos related to

Sort By:
Pageof 38
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2024
Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter ApproachCatalina Amador, Dennis D Weisenburger, Ana Gomez, et al.
Leukemia|February 19, 2026
Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphomaDaniel Filip, Katerina Litzmanova, Androniki Michaelou, et al.
Genes, Chromosomes & Cancer|January 23, 2025
MicroRNA Expression in High-Grade B-Cell Lymphoma With 11q AberrationGioia Di Stefano, Anja Fischer, Emil Chteinberg, et al.
Nature Communications|July 6, 2022
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to ageBirgit Burkhardt, Ulf Michgehl, Jonas Rohde, et al.
The American Journal of Pathology|June 25, 2004
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphomaJaveed Iqbal, Warren G Sanger, Douglas E Horsman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOPXin Huang, Bin Meng, Javeed Iqbal, et al.
Blood|February 15, 2007
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survivalAdrian Wiestner, Mahsa Tehrani, Michael Chiorazzi, et al.
Leukemia|July 19, 2022
PARP14 is a novel target in STAT6 mutant follicular lymphomaMichael Mentz, William Keay, Carolin Dorothea Strobl, et al.
Blood|September 21, 2013
EZH2 mutations are frequent and represent an early event in follicular lymphomaCsaba Bödör, Vera Grossmann, Nikolay Popov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2017
New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded BiopsiesDavid W Scott, Pau Abrisqueta, George W Wright, et al.
Pageof 38